Chemomab Therapeutics Ltd. (CMMB) Net income 2018–2025
Chemomab Therapeutics Ltd. (CMMB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$9.0MFY2025 · since FY2018: -$13.8M → -$9.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.0M | +35.5% |
| FY2024 | -$13.9M | +42.4% |
| FY2023 | -$24.2M | +12.4% |
| FY2022 | -$27.6M | -121.6% |
| FY2021 | -$12.5M | -109.7% |
| FY2020 | -$6.0M | +78.1% |
| FY2019 | -$27.1M | -96.6% |
| FY2018 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice